IMMUNOVANT INC (IMVT)
US45258J1025 - Common Stock
| TTM (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -243.45M | -210.96M | -156.73M | -107.43M | -66.39M | |||
| Depreciation Amortization | 217.00K | 190.00K | 130.00K | 70.00K | 20.00K | |||
| Change In Working Capital | -7.23M | -10.85M | 15.14M | 4.57M | 4.81M | |||
| Taxes Paid | N/A | N/A | 0.00 | 170.00K | 60.00K | |||
| Other non cash items | 40.16M | 33.43M | 35.35M | 19.47M | 8.20M | |||
| OPERATING CASH FLOW | -210.32M | -188.19M | -106.11M | -83.33M | -53.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -240.00K | -200.00K | -250.00K | -210.00K | -30.00K | |||
| INVESTING CASH FLOW | -240.00K | -200.00K | -250.00K | -210.00K | -30.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -3.19M | 37.91M | |||
| Stock Issued/Repurchased | 477.13M | 71.16M | 0.00 | 386.44M | 0.00 | |||
| Other Financing Activity | N/A | -270.00K | 200.13M | -140.00K | 109.07M | |||
| FINANCING CASH FLOW | 471.12M | 70.89M | 200.13M | 383.11M | 146.97M | |||
| Exchange Rate Effect | -2.23M | 220.00K | -90.00K | N/A | N/A | |||
| CHANGE IN CASH | 258.33M | -117.28M | 93.68M | 299.57M | 93.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -210.32M | -188.19M | -106.11M | -83.33M | -53.36M | |||
| Capital Expenditure | -240.00K | -200.00K | -250.00K | -210.00K | -30.00K | |||
| FREE CASH FLOW | -210.56M | -188.39M | -106.36M | -83.54M | -53.39M | |||
All data in USD